451 related articles for article (PubMed ID: 37185833)
21. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
23. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19.
Li T; Wang D; Wei H; Xu X
Front Med; 2023 Dec; 17(6):1080-1095. PubMed ID: 38157195
[TBL] [Abstract][Full Text] [Related]
24. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
25. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
[TBL] [Abstract][Full Text] [Related]
26. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein.
Gasparello J; D'Aversa E; Papi C; Gambari L; Grigolo B; Borgatti M; Finotti A; Gambari R
Phytomedicine; 2021 Jul; 87():153583. PubMed ID: 34033999
[TBL] [Abstract][Full Text] [Related]
27. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
Fara A; Mitrev Z; Rosalia RA; Assas BM
Open Biol; 2020 Sep; 10(9):200160. PubMed ID: 32961074
[TBL] [Abstract][Full Text] [Related]
28. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
Machado C; González-Quevedo A
MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
[TBL] [Abstract][Full Text] [Related]
29. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
Wang J; Jiang M; Chen X; Montaner LJ
J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
[TBL] [Abstract][Full Text] [Related]
30. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
31. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
Norooznezhad AH; Mansouri K
Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
[TBL] [Abstract][Full Text] [Related]
32. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
33. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
34. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
[TBL] [Abstract][Full Text] [Related]
35. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.
Kalinina O; Golovkin A; Zaikova E; Aquino A; Bezrukikh V; Melnik O; Vasilieva E; Karonova T; Kudryavtsev I; Shlyakhto E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012146
[TBL] [Abstract][Full Text] [Related]
36. Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
Stolarski AE; Kim J; Zhang Q; Remick DG
Shock; 2021 Nov; 56(5):667-672. PubMed ID: 34652339
[TBL] [Abstract][Full Text] [Related]
37. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
38. Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2.
Ng WH; Tang PCH; Mahalingam S; Liu X
Br J Pharmacol; 2023 Jan; 180(2):133-143. PubMed ID: 36394425
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.
Chukwuma IF; Apeh VO; Chiletugo OF
Acta Virol; 2021; 65(1):3-9. PubMed ID: 33112637
[TBL] [Abstract][Full Text] [Related]
40. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
Manik M; Singh RK
J Med Virol; 2022 Mar; 94(3):869-877. PubMed ID: 34672376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
